Author
Listed:
- Xue Li
(School of Public Health, Xinxiang Medical University, Xinxiang 453003, China
Centre for Population Health Sciences, University of Edinburgh, Edinburgh EH8 9AG, UK)
- Peige Song
(School of Public Health, Xinxiang Medical University, Xinxiang 453003, China
Centre for Population Health Sciences, University of Edinburgh, Edinburgh EH8 9AG, UK)
- Jun Li
(The 153 Hospital of People’s Liberation Army, Zhengzhou 450001, China)
- Yuchang Tao
(School of Public Health, Xinxiang Medical University, Xinxiang 453003, China)
- Guowei Li
(Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, ON L8S 4L8, Canada)
- Xiumin Li
(Department Gastroenterology, the First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, China)
- Zengli Yu
(School of Public Health, Xinxiang Medical University, Xinxiang 453003, China)
Abstract
The temporal trend of inflammatory bowel disease (IBD) incidence is reported to be increasing in worldwide regions; however, reports focusing on China are sparse. The aim of this study was to provide an overview of the disease burden and clinical features of IBD in the Chinese population. We searched Medline, EMBASE, and another two Chinese databases. A parallel literature review and data extraction were conducted. Meta-analysis was performed to estimate the summary incidence rate of Crohn’s disease (CD) and ulcerative colitis (UC). The constituent ratios with 95% CI were calculated for clinical phenotypes and classifications. The literature review included 47 publications. The summary incidence rate of IBD was 1.74 (95% CI: 1.08; 2.40) per 100,000 person years, and the corresponding incidence rates of CD and UC were 0.40 (95% CI: 0.23; 0.57) and 1.18 (95% CI: 0.81; 1.56) per 100,000 person years, respectively. The sex distribution analysis indicated a male predominance in both CD (sex ratio: 1.64; 95% CI: 1.47–1.84) and UC (sex ratio: 1.29; 95% CI: 1.21–1.38). The clinical characteristics were summarized using data from 2283 CD cases and 17,958 UC cases; in which the majority of CD patients were diagnosed between 17–40 years of age, with non-stricturing and non-penetrating disease, varied disease locations, and less extra-intestinal manifestation. UC cases were featured with later disease diagnosis, a more severe disease course, more segmental lesions, and less extra-intestinal manifestations. Our study provided an estimated disease burden of IBD and demonstrated distinct clinical features in the Chinese population. Large-scale population-based studies are needed to further evaluate these findings.
Suggested Citation
Xue Li & Peige Song & Jun Li & Yuchang Tao & Guowei Li & Xiumin Li & Zengli Yu, 2017.
"The Disease Burden and Clinical Characteristics of Inflammatory Bowel Disease in the Chinese Population: A Systematic Review and Meta-Analysis,"
IJERPH, MDPI, vol. 14(3), pages 1-12, February.
Handle:
RePEc:gam:jijerp:v:14:y:2017:i:3:p:238-:d:91751
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:14:y:2017:i:3:p:238-:d:91751. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.